United Therapeutics Corporation Earnings Per Share (Basic)
United Therapeutics Corporation (UTHR) reported Earnings Per Share (Basic) of $7.82 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-05
- United Therapeutics Corporation earnings per share, basic for the quarter ending 2026-06-30 was $7.82, a 13.99% increase year-over-year.
- United Therapeutics Corporation earnings per share, basic for the quarter ending 2026-03-31 was $6.32, a 11.98% decline year-over-year.
- United Therapeutics Corporation earnings per share, basic for the quarter ending 2025-09-30 was $7.73, a 11.54% increase year-over-year.
- United Therapeutics Corporation earnings per share, basic for the quarter ending 2025-06-30 was $6.86, a 9.58% increase year-over-year.
- United Therapeutics Corporation earnings per share, basic for fiscal 2025 was $30.13, a 13.96% increase from fiscal 2024.
- United Therapeutics Corporation earnings per share, basic for fiscal 2024 was $26.44, a 25.67% increase from fiscal 2023.
- United Therapeutics Corporation earnings per share, basic for fiscal 2023 was $21.04, a 31.66% increase from fiscal 2022.
- United Therapeutics Corporation earnings per share, basic for fiscal 2022 was $15.98, a 50.75% increase from fiscal 2021.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | $7.82 10-Q · filed 2026-08-05 | $14.14 10-Q · filed 2026-08-05 | ||
| 2026-03-31 | $6.32 10-Q · filed 2026-05-06 | |||
| 2025-12-31 | $30.13 10-K · filed 2026-02-25 | |||
| 2025-09-30 | $7.73 10-Q · filed 2025-10-29 | $21.76 10-Q · filed 2025-10-29 | ||
| 2025-06-30 | $6.86 10-Q · filed 2026-08-05 | $14.04 10-Q · filed 2026-08-05 | ||
| 2025-03-31 | $7.18 10-Q · filed 2026-05-06 | |||
| 2024-12-31 | $26.44 10-K · filed 2026-02-25 | |||
| 2024-09-30 | $6.93 10-Q · filed 2025-10-29 | $19.73 10-Q · filed 2025-10-29 | ||
| 2024-06-30 | $6.26 10-Q · filed 2025-07-30 | $12.79 10-Q · filed 2025-07-30 | ||
| 2024-03-31 | $6.52 10-Q · filed 2025-04-30 | |||
| 2023-12-31 | $21.04 10-K · filed 2026-02-25 | |||
| 2023-09-30 | $5.71 10-Q · filed 2024-10-30 | $16.44 10-Q · filed 2024-10-30 | ||
| 2023-06-30 | $5.53 10-Q · filed 2024-07-31 | $10.73 10-Q · filed 2024-07-31 | ||
| 2023-03-31 | $5.20 10-Q · filed 2024-05-01 | |||
| 2022-12-31 | $15.98 10-K · filed 2025-02-26 | |||
| 2022-09-30 | $5.26 10-Q · filed 2023-11-01 | $13.14 10-Q · filed 2023-11-01 | ||
| 2022-06-30 | $2.56 10-Q · filed 2023-08-02 | $7.86 10-Q · filed 2023-08-02 | ||
| 2022-03-31 | $5.31 10-Q · filed 2023-05-03 | |||
| 2021-12-31 | $10.60 10-K · filed 2024-02-21 | |||
| 2021-09-30 | $3.62 10-Q · filed 2022-11-02 | $8.12 10-Q · filed 2022-11-02 | ||
| 2021-06-30 | $3.85 10-Q · filed 2022-08-03 | $4.49 10-Q · filed 2022-08-03 | ||
| 2021-03-31 | $0.63 10-Q · filed 2022-05-04 | |||
| 2020-12-31 | $11.65 10-K · filed 2023-02-22 | |||
| 2020-09-30 | $3.86 10-Q · filed 2021-11-03 | $9.43 10-Q · filed 2021-11-03 | ||
| 2020-06-30 | $2.43 10-Q · filed 2021-08-04 | $5.56 10-Q · filed 2021-08-04 | ||
| 2020-03-31 | $3.14 10-Q · filed 2021-05-05 | $4.34 derived: net income ÷ weighted average shares · filed 2022-02-24 | $7.36 derived: net income ÷ weighted average shares · filed 2022-02-24 | $12.04 derived: net income ÷ weighted average shares · filed 2022-02-24 |
| 2019-12-31 | $1.20 10-K · filed 2020-02-26 | $4.22 derived: net income ÷ weighted average shares · filed 2022-02-24 | $8.90 derived: net income ÷ weighted average shares · filed 2022-02-24 | -$2.39 10-K · filed 2022-02-24 |
| 2019-09-30 | $3.02 10-Q · filed 2020-10-28 | $7.70 derived: net income ÷ weighted average shares · filed 2020-10-28 | -$3.59 10-Q · filed 2020-10-28 | -$2.10 derived: net income ÷ weighted average shares · filed 2021-02-24 |
| 2019-06-30 | $4.68 10-Q · filed 2020-07-29 | -$6.61 10-Q · filed 2020-07-29 | -$5.13 derived: net income ÷ weighted average shares · filed 2021-02-24 | -$2.70 derived: net income ÷ weighted average shares · filed 2021-02-24 |
| 2019-03-31 | -$11.32 10-Q · filed 2020-04-29 | -$9.85 derived: net income ÷ weighted average shares · filed 2021-02-24 | -$7.40 derived: net income ÷ weighted average shares · filed 2021-02-24 | -$3.45 derived: net income ÷ weighted average shares · filed 2021-02-24 |
| 2018-12-31 | $1.50 10-K · filed 2020-02-26 | $3.94 derived: net income ÷ weighted average shares · filed 2021-02-24 | $7.94 derived: net income ÷ weighted average shares · filed 2021-02-24 | $13.54 10-K · filed 2021-02-24 |
| 2018-09-30 | $2.44 10-K · filed 2020-02-26 | $6.45 derived: net income ÷ weighted average shares · filed 2020-02-26 | $12.04 10-Q · filed 2019-10-30 | $12.55 derived: net income ÷ weighted average shares · filed 2020-02-26 |
| 2018-06-30 | $4.01 10-K · filed 2020-02-26 | $9.62 10-Q · filed 2019-07-31 | $10.11 derived: net income ÷ weighted average shares · filed 2020-02-26 | $16.49 derived: net income ÷ weighted average shares · filed 2020-02-26 |
| 2018-03-31 | $5.65 10-K · filed 2020-02-26 | $6.10 derived: net income ÷ weighted average shares · filed 2020-02-26 | $12.48 derived: net income ÷ weighted average shares · filed 2020-02-26 | $11.08 derived: net income ÷ weighted average shares · filed 2020-02-26 |
| 2017-12-31 | $0.44 10-K · filed 2019-02-27 | $6.83 derived: net income ÷ weighted average shares · filed 2020-02-26 | $5.46 derived: net income ÷ weighted average shares · filed 2020-02-26 | $9.50 10-K · filed 2020-02-26 |
| 2017-09-30 | $6.37 10-K · filed 2019-02-27 | $4.99 derived: net income ÷ weighted average shares · filed 2019-02-27 | $9.00 10-Q · filed 2018-10-31 | $11.63 derived: net income ÷ weighted average shares · filed 2019-02-27 |
| 2017-06-30 | -$1.25 10-K · filed 2019-02-27 | $2.74 10-Q · filed 2018-08-01 | $5.31 derived: net income ÷ weighted average shares · filed 2019-02-27 | $9.03 derived: net income ÷ weighted average shares · filed 2019-02-27 |
| 2017-03-31 | $4.01 10-K · filed 2019-02-27 | $6.66 derived: net income ÷ weighted average shares · filed 2019-02-27 | $10.40 derived: net income ÷ weighted average shares · filed 2019-02-27 | $15.07 derived: net income ÷ weighted average shares · filed 2019-02-27 |
| 2016-12-31 | $2.61 10-K · filed 2018-02-21 | $6.36 derived: net income ÷ weighted average shares · filed 2019-02-27 | $11.05 derived: net income ÷ weighted average shares · filed 2019-02-27 | $16.29 10-K · filed 2019-02-27 |
| 2016-09-30 | $3.75 10-K · filed 2018-02-21 | $8.41 derived: net income ÷ weighted average shares · filed 2018-02-21 | $13.62 10-Q · filed 2017-10-25 | $15.86 derived: net income ÷ weighted average shares · filed 2018-02-21 |
| 2016-06-30 | $4.65 10-K · filed 2018-02-21 | $9.86 10-Q · filed 2017-07-27 | $12.10 derived: net income ÷ weighted average shares · filed 2018-02-21 | $22.35 derived: net income ÷ weighted average shares · filed 2018-02-21 |
| 2016-03-31 | $5.19 10-K · filed 2018-02-21 | $7.47 derived: net income ÷ weighted average shares · filed 2018-02-21 | $17.67 derived: net income ÷ weighted average shares · filed 2018-02-21 | $19.79 derived: net income ÷ weighted average shares · filed 2018-02-21 |
| 2015-12-31 | $2.29 10-K · filed 2017-02-22 | $12.48 derived: net income ÷ weighted average shares · filed 2018-02-21 | $14.60 derived: net income ÷ weighted average shares · filed 2018-02-21 | $14.17 10-K · filed 2018-02-21 |
| 2015-09-30 | $10.20 10-K · filed 2017-02-22 | $12.31 derived: net income ÷ weighted average shares · filed 2017-02-22 | $11.86 10-Q · filed 2016-10-27 | $14.27 derived: net income ÷ weighted average shares · filed 2017-02-22 |
| 2015-06-30 | $2.15 10-K · filed 2017-02-22 | $1.78 10-Q · filed 2016-07-28 | $4.24 derived: net income ÷ weighted average shares · filed 2017-02-22 | $3.69 derived: net income ÷ weighted average shares · filed 2017-02-22 |
| 2015-03-31 | -$0.36 10-K · filed 2017-02-22 | $2.11 derived: net income ÷ weighted average shares · filed 2017-02-22 | $1.57 derived: net income ÷ weighted average shares · filed 2017-02-22 | $3.93 derived: net income ÷ weighted average shares · filed 2017-02-22 |
| 2014-12-31 | $2.44 10-K · filed 2016-02-25 | $1.91 derived: net income ÷ weighted average shares · filed 2017-02-22 | $4.27 derived: net income ÷ weighted average shares · filed 2017-02-22 | $7.06 10-K · filed 2017-02-22 |
| 2014-09-30 | -$0.53 10-K · filed 2016-02-25 | $1.83 derived: net income ÷ weighted average shares · filed 2016-02-25 | $4.63 10-Q · filed 2015-10-27 | $3.96 derived: net income ÷ weighted average shares · filed 2016-02-25 |
| 2014-06-30 | $2.35 10-K · filed 2016-02-25 | $5.09 10-Q · filed 2015-07-28 | $4.43 derived: net income ÷ weighted average shares · filed 2016-02-25 | $5.68 derived: net income ÷ weighted average shares · filed 2016-02-25 |
| 2014-03-31 | $2.73 10-K · filed 2016-02-25 | $2.13 derived: net income ÷ weighted average shares · filed 2016-02-25 | $3.38 derived: net income ÷ weighted average shares · filed 2016-02-25 | $4.98 derived: net income ÷ weighted average shares · filed 2016-02-25 |
| 2013-12-31 | -$0.60 10-K · filed 2015-02-24 | $0.65 derived: net income ÷ weighted average shares · filed 2016-02-25 | $2.24 derived: net income ÷ weighted average shares · filed 2016-02-25 | $3.49 10-K · filed 2016-02-25 |
| 2013-09-30 | $1.25 10-K · filed 2015-02-24 | $2.86 derived: net income ÷ weighted average shares · filed 2015-02-24 | $4.10 10-Q · filed 2014-10-28 | $5.75 derived: net income ÷ weighted average shares · filed 2015-02-24 |
| 2013-06-30 | $1.60 10-K · filed 2015-02-24 | $2.84 10-Q · filed 2014-07-29 | $4.49 derived: net income ÷ weighted average shares · filed 2015-02-24 | $6.01 derived: net income ÷ weighted average shares · filed 2015-02-24 |
| 2013-03-31 | $1.24 10-K · filed 2015-02-24 | $2.89 derived: net income ÷ weighted average shares · filed 2015-02-24 | $4.41 derived: net income ÷ weighted average shares · filed 2015-02-24 | $5.78 derived: net income ÷ weighted average shares · filed 2015-02-24 |
| 2012-12-31 | $1.65 10-K · filed 2014-02-25 | $3.16 derived: net income ÷ weighted average shares · filed 2015-02-24 | $4.53 derived: net income ÷ weighted average shares · filed 2015-02-24 | $5.84 10-K · filed 2015-02-24 |
| 2012-09-30 | $1.52 10-K · filed 2014-02-25 | $2.89 derived: net income ÷ weighted average shares · filed 2014-02-25 | $4.20 10-Q · filed 2013-10-29 | $4.98 derived: net income ÷ weighted average shares · filed 2014-02-25 |
| 2012-06-30 | $1.37 10-K · filed 2014-02-25 | $2.69 10-Q · filed 2013-07-25 | $3.48 derived: net income ÷ weighted average shares · filed 2014-02-25 | $4.94 derived: net income ÷ weighted average shares · filed 2014-02-25 |
| 2012-03-31 | $1.32 10-K · filed 2014-02-25 | $2.11 derived: net income ÷ weighted average shares · filed 2014-02-25 | $3.58 derived: net income ÷ weighted average shares · filed 2014-02-25 | $4.85 derived: net income ÷ weighted average shares · filed 2014-02-25 |
| 2011-12-31 | $0.79 10-K · filed 2013-02-26 | $2.26 derived: net income ÷ weighted average shares · filed 2014-02-25 | $3.54 derived: net income ÷ weighted average shares · filed 2014-02-25 | $3.81 10-K · filed 2014-02-25 |
| 2011-09-30 | $1.45 10-K · filed 2013-02-26 | $2.72 derived: net income ÷ weighted average shares · filed 2013-02-26 | $3.01 10-Q · filed 2012-11-01 | $3.18 derived: net income ÷ weighted average shares · filed 2013-02-26 |
| 2011-06-30 | $1.27 10-K · filed 2013-02-26 | $1.56 10-Q · filed 2012-07-26 | $1.73 derived: net income ÷ weighted average shares · filed 2013-02-26 | $2.43 derived: net income ÷ weighted average shares · filed 2013-02-26 |
| 2011-03-31 | $0.28 10-K · filed 2013-02-26 | $0.45 derived: net income ÷ weighted average shares · filed 2013-02-26 | $1.15 derived: net income ÷ weighted average shares · filed 2013-02-26 | $1.82 derived: net income ÷ weighted average shares · filed 2013-02-26 |
| 2010-12-31 | $0.17 10-K · filed 2012-02-28 | $0.87 derived: net income ÷ weighted average shares · filed 2013-02-26 | $1.54 derived: net income ÷ weighted average shares · filed 2013-02-26 | $1.89 10-K · filed 2013-02-26 |
| 2010-09-30 | $0.70 10-K · filed 2012-02-28 | $1.38 derived: net income ÷ weighted average shares · filed 2012-02-28 | $1.73 10-Q · filed 2011-10-27 | |
| 2010-06-30 | $0.67 10-K · filed 2012-02-28 | $1.02 10-Q · filed 2011-07-28 | ||
| 2010-03-31 | $0.35 10-K · filed 2012-02-28 | |||
| 2009-12-31 | $0.37 10-K · filed 2012-02-28 | |||
| 2009-09-30 | $0.22 10-Q · filed 2010-10-28 | $0.43 10-Q · filed 2010-10-28 | ||
| 2009-06-30 | -$0.04 10-Q · filed 2010-07-28 | $0.21 10-Q · filed 2010-07-28 | ||
| 2008-12-31 | -$1.08 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |